Your healthcare provider may tell you to take XIGDUO XR along with other diabetes medicines
Issa says
Based on animal studies, it warns that GLP-1 receptor agonists like semaglutide should not be used in pregnancy due to potential risks of embryofetal mortality, structural abnormalities, and alterations to growth. The journal underscores the lack of human data and advises women planning to get pregnant to discontinue semaglutide at least two months beforehand
Debashrees research supports organizations in adopting technology-driven healthcare solutions, improving patient care, and achieving operational efficiency in a rapidly transforming healthcare ecosystem.
As the insulinotropic capacity of GLP-1 is partially retained in diabetic humans, GLP-1-based treatments have been successfully developed
The visit includes medical history review, weight and metabolic screening, and GLP-1 prescription issuance if clinically appropriate